[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017 France Therapeutic Drug Monitoring (TDM) Market: Future Horizons and Growth Strategies--Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2017 | 247 pages | ID: FA8BC848DADEN
Venture Planning Group

US$ 2,205.00 US$ 2,450.00 -10 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the French therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition.

Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This report is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.

Contains 247 pages and 17 tables
INTRODUCTION

WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Major Therapeutic Drug Monitoring Tests
  1. O5ER6EW
  2. CARBAMAZEP1NE
  3. CYCLOSPOR1N
  4. D1GO11N
  5. E5EROL1MUS
  6. GENTAM1C1N
  7. LAMOTR1G1NE/LAM1CTAL
  8. LE5ET1RACETAM
  9. L1DOCA1NE
  10. L1TH1UM
  11. PHENYTO1N
  12. NAPA/PROCA1NAM1DE
  13. QU1N1D1NE
  14. S1ROL1MUS
  15. TACROL1MUS
  16. TOP1R1MATE
  17. THEOPHYLL1NE
  18. 5ALPRO1C AC1D
B. 1nstrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers manufactured by Abaxis, Abbott, Alere/1nverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, 5ital Diagnostics and other suppliers
C. Major 1n 5itro Diagnostic Technologies And Their Potential Applications
  1. MONOCLONAL AND POLYCLONAL ANT1BOD1ES
  2. 1MMUNOASSAYS
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme 1mmunoassays (E1A)
      Overview
      EL1SA
      EM1T
      Electrochemical
    d. Radioimmunoassays (R1A)
    e. 1mmunoprecipitation
    f. Affinity Chromatography
  3. TANDEM MASS SPEC
  4. 1T AND AUTOMAT1ON
  5. DRY CHEM1STRY
  6. B1OSENSORS
D. Market Size, Growth and Major Supplier Shares

ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

COMPETITIVE ASSESSMENTS

Abbott Laboratories
AdnaGen/Alere
Agilent Technologies
Bayer Healthcare
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
DiaSorin
Eiken
Fujirebio
Grifols
1nstrumentation Laboratory
Kyowa Medex
Matritech/Alere
Ortho-Clinical Diagnostics
Quest Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

L1ST OF TABLES

Major Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing 5alproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
France, Laboratories Performing TDM Tests By Market Segment
France, Hospital Laboratories Performing TDM Tests By Bed Size
France, Commercial/Private Laboratories Performing TDM Tests By Annual Test 5olume
France, TDM Test 5olume Forecast By Market Segment
France, Hospital Laboratories, TDM Test 5olume Forecast by Assay
France, Commercial/Private Laboratories, TDM Test 5olume Forecast by Assay
France, TDM Reagent Market Forecast By Market Segment
France, Hospital Laboratories, TDM Diagnostics Market Forecast by Assay
France, Commercial/Private Laboratories, TDM Diagnostics Market Forecast by Assay
France, Major Suppliers of 1mmunodiagnostic Products, Estimated Market Shares


More Publications